Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126110153 | 12611015 | 3 | F | 20160817 | 20160801 | 20160829 | PER | US-PFIZER INC-2016356764 | PFIZER | 72.00 | YR | F | Y | 51.00000 | KG | 20160829 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126110153 | 12611015 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | ()25 MG, 1X/DAY | 21938 | 25 | MG | CAPSULE, HARD | QD | ||||||
| 126110153 | 12611015 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (4 WEEKS ON/2WEEKS OFF) | 21938 | 25 | MG | CAPSULE, HARD | ||||||||
| 126110153 | 12611015 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, DAILY (FOR 3 WEEKS) | 21938 | 50 | MG | CAPSULE, HARD | ||||||||
| 126110153 | 12611015 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (DAILY FOR 2 WEEKS ON/ 1WEEK OFF) | 21938 | 25 | MG | CAPSULE, HARD | ||||||||
| 126110153 | 12611015 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, 1X/DAY (AT NIGHT) | 21938 | 25 | MG | CAPSULE, HARD | QD | ||||||
| 126110153 | 12611015 | 6 | C | ACYCLOVIR. | ACYCLOVIR | 1 | UNK UNK, 3X/DAY (5%) | 0 | TID | ||||||||||
| 126110153 | 12611015 | 7 | C | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, 2X/DAY | 0 | 2.5 | MG | TABLET | BID | ||||||
| 126110153 | 12611015 | 8 | C | AZOPT | BRINZOLAMIDE | 1 | 1 GTT, 3X/DAY (PLACE 1 DROP INTO BOTH EYES 3 TIMES DAILY) | 0 | 1 | GTT | TID | ||||||||
| 126110153 | 12611015 | 9 | C | AZOPT | BRINZOLAMIDE | 1 | 1 %, UNK | 0 | 1 | PCT | |||||||||
| 126110153 | 12611015 | 10 | C | DIALYVITE | ASCORBIC ACIDBIOTINCALCIUM PANTOTHENATECOBALAMINFOLIC ACIDNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATE | 1 | Oral | UNK | 0 | ||||||||||
| 126110153 | 12611015 | 11 | C | LUMIGAN | BIMATOPROST | 1 | 1 GTT, 1X/DAY | 0 | 1 | GTT | QD | ||||||||
| 126110153 | 12611015 | 12 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 126110153 | 12611015 | 13 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 126110153 | 12611015 | 14 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | UNK, AS NEEDED | 0 | TABLET | |||||||||
| 126110153 | 12611015 | 15 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 126110153 | 12611015 | 16 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 126110153 | 12611015 | 17 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | CAPSULE | |||||||
| 126110153 | 12611015 | 18 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, AS NEEDED | 0 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126110153 | 12611015 | 1 | Metastatic renal cell carcinoma |
| 126110153 | 12611015 | 6 | Oral pain |
| 126110153 | 12611015 | 14 | Pain |
| 126110153 | 12611015 | 18 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126110153 | 12611015 | HO |
| 126110153 | 12611015 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126110153 | 12611015 | Anaemia | |
| 126110153 | 12611015 | Back pain | |
| 126110153 | 12611015 | Decreased appetite | |
| 126110153 | 12611015 | Diarrhoea | |
| 126110153 | 12611015 | Disease progression | |
| 126110153 | 12611015 | Fall | |
| 126110153 | 12611015 | Fatigue | |
| 126110153 | 12611015 | Infection | |
| 126110153 | 12611015 | Lymphoedema | |
| 126110153 | 12611015 | Metastatic renal cell carcinoma | |
| 126110153 | 12611015 | Oral pain | |
| 126110153 | 12611015 | Peripheral swelling | |
| 126110153 | 12611015 | Pneumonia | |
| 126110153 | 12611015 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126110153 | 12611015 | 1 | 20141014 | 0 | ||
| 126110153 | 12611015 | 3 | 20150305 | 0 | ||
| 126110153 | 12611015 | 4 | 20150426 | 0 | ||
| 126110153 | 12611015 | 5 | 201607 | 0 | ||
| 126110153 | 12611015 | 6 | 20141112 | 0 | ||
| 126110153 | 12611015 | 8 | 20140509 | 0 | ||
| 126110153 | 12611015 | 11 | 20140509 | 0 | ||
| 126110153 | 12611015 | 18 | 20151029 | 0 |